Dr Daniel P Putnam, MD - Medicare Ophthalmology in Moorestown, NJ

Dr Daniel P Putnam, MD is a medicare enrolled "Ophthalmology" physician in Moorestown, New Jersey. He went to University Of Texas Southwestern Medical School At Dallas and graduated in 1989 and has 35 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Associated Retinal Consultants Llc and his current practice location is 509 S Lenola Rd Ste 11a, Moorestown, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 234-0258.

Dr Daniel P Putnam is licensed to practice in New Jersey (license number 25MA07142000) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1427055508.

Contact Information

Dr Daniel P Putnam, MD
509 S Lenola Rd Ste 11a,
Moorestown, NJ 08057-1561
(856) 234-0258
(856) 727-9518



Physician's Profile

Full NameDr Daniel P Putnam
GenderMale
SpecialityOphthalmology
Experience35 Years
Location509 S Lenola Rd Ste 11a, Moorestown, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Daniel P Putnam attended and graduated from University Of Texas Southwestern Medical School At Dallas in 1989
  NPI Data:
  • NPI Number: 1427055508
  • Provider Enumeration Date: 07/05/2005
  • Last Update Date: 04/12/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0446383293
  • Enrollment ID: I20100802000014

Medical Identifiers

Medical identifiers for Dr Daniel P Putnam such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1427055508NPI-NPPES
8407207MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology MD418189 (Pennsylvania)Secondary
207W00000XOphthalmology 25MA07142000 (New Jersey)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Associated Retinal Consultants Llc2961509161114

News Archive

WHO declares Ebola outbreak in Democratic Republic of Congo now over

The World Health Organization (WHO) declared the end of the latest Ebola virus disease (EVD) outbreak in the Democratic Republic of Congo (DRC) last Saturday. This comes at 42 days after the last confirmed case of Ebola. The experts have said that two incubation period cycles of 21 days have passed with no new cases and thus it can be safely said that the outbreak has ended.

Winner Medical announces launch of PurCotton Business-to-Customer online store

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced that it has launches its own PurCotton® Business-to-Customer (B2C) online store at www.purcotton.com.

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

Obama, Bill Clinton to promote health law next week

A week before new health insurance marketplaces open for enrollment, President Barack Obama will join former President Bill Clinton in New York to have "a conversation about the benefits and future of health care reform."

Poor children at greater risk for exposure to toxic pollutants

Poor and ethnic minority children in the United States have a significantly greater risk for exposure to toxic pollutants that can affect their cognitive development and other health indicators than higher income and non-minority peers, and current local, state and federal policies appear to be failing to address these inequities.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Daniel P Putnam allows following entities to bill medicare on his behalf.
Entity NameAssociated Retinal Consultants Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164578894
PECOS PAC ID: 2961509161
Enrollment ID: O20070523000337

News Archive

WHO declares Ebola outbreak in Democratic Republic of Congo now over

The World Health Organization (WHO) declared the end of the latest Ebola virus disease (EVD) outbreak in the Democratic Republic of Congo (DRC) last Saturday. This comes at 42 days after the last confirmed case of Ebola. The experts have said that two incubation period cycles of 21 days have passed with no new cases and thus it can be safely said that the outbreak has ended.

Winner Medical announces launch of PurCotton Business-to-Customer online store

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced that it has launches its own PurCotton® Business-to-Customer (B2C) online store at www.purcotton.com.

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

Obama, Bill Clinton to promote health law next week

A week before new health insurance marketplaces open for enrollment, President Barack Obama will join former President Bill Clinton in New York to have "a conversation about the benefits and future of health care reform."

Poor children at greater risk for exposure to toxic pollutants

Poor and ethnic minority children in the United States have a significantly greater risk for exposure to toxic pollutants that can affect their cognitive development and other health indicators than higher income and non-minority peers, and current local, state and federal policies appear to be failing to address these inequities.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Daniel P Putnam is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Daniel P Putnam, MD
509 S Lenola Rd Ste 11a,
Moorestown, NJ 08057-1561

Ph: (856) 234-0258
Dr Daniel P Putnam, MD
509 S Lenola Rd Ste 11a,
Moorestown, NJ 08057-1561

Ph: (856) 234-0258

News Archive

WHO declares Ebola outbreak in Democratic Republic of Congo now over

The World Health Organization (WHO) declared the end of the latest Ebola virus disease (EVD) outbreak in the Democratic Republic of Congo (DRC) last Saturday. This comes at 42 days after the last confirmed case of Ebola. The experts have said that two incubation period cycles of 21 days have passed with no new cases and thus it can be safely said that the outbreak has ended.

Winner Medical announces launch of PurCotton Business-to-Customer online store

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced that it has launches its own PurCotton® Business-to-Customer (B2C) online store at www.purcotton.com.

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.

Obama, Bill Clinton to promote health law next week

A week before new health insurance marketplaces open for enrollment, President Barack Obama will join former President Bill Clinton in New York to have "a conversation about the benefits and future of health care reform."

Poor children at greater risk for exposure to toxic pollutants

Poor and ethnic minority children in the United States have a significantly greater risk for exposure to toxic pollutants that can affect their cognitive development and other health indicators than higher income and non-minority peers, and current local, state and federal policies appear to be failing to address these inequities.

Read more News

› Verified 4 days ago


Ophthalmology Doctors in Moorestown, NJ

Cathy Yx Zhang, MD
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 509 S Lenola Rd # 11-a, Moorestown, NJ 08057
Phone: 856-234-0222    
Michael Colucciello Iii, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057
Phone: 856-234-0258    Fax: 856-727-9518
Miriam R Brown, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057
Phone: 856-234-0258    Fax: 856-727-9518
Amy R Wexler, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057
Phone: 856-234-0258    Fax: 856-727-9518
Dr. Trong D Tran, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 509 S Lenola Rd Ste 11a, Moorestown, NJ 08057
Phone: 856-234-0258    Fax: 856-727-9518
Dr. Sharad Sunder Mansukani, MD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 411 Park Ln, Moorestown, NJ 08057
Phone: 856-234-4382    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.